Haven't had much time lately? Here's what you may have missed in the last few months
New in 2015: Hairy Cell Leukaemia, Myeloproliferative Neoplasms, Thymic Epithelial Tumours, Central Venous Access, Treatment of Dyspnoea
28 Jul 2016
Research raises possibility of concurrent radium-223 and anti-androgen treatment for progressing metastatic castration-resistant prostate cancer
27 Jul 2016
Overall survival in patients with extensive-stage small-cell lung cancer is not changed with ipilimumab augmentation of chemotherapy
26 Jul 2016
Inoperable, radioactive iodine-refractory papillary thyroid cancer with a BRAFV600E mutation may respond to vemurafenib
26 Jul 2016
Tanja Cufer discusses the abstracts presented in lung cancer track at ASCO 2016 Annual Congress. Due to treatment advances and longer lifespan in NSCLC...
25 Jul 2016
Likelihood of breast preservation for women with second breast events is influenced by regional variation in treatment intensity for ductal carcinoma...
Tanja Cufer discusses the abstracts presented in lung cancer track at ASCO 2016 Annual Congress. Due to treatment advances and longer lifespan in NSCLC patients with oncogene-driven disease, brain and leptomeningeal metastases are nowadays often. She discusses the efficacy results from several newer agents in that setting. In addition, she discusses the results with a new Antibody-drug conjugate in metastatic setting, as well as milestone analyses with immune checkpoint inhibitors, targeted therapy and standard therapy in trials submitted to the US FDA.